Targeting Nicotinic Receptor Antagonists as Novel Pharmacotherapies for Tobacco Dependence and Relapse

Documenti analoghi

• Nicotinic Receptor Antagonists as Treatments for Nicotine Abuse
  di: Crooks, Peter A., et al.
  Pubblicazione: (2014)
• Targeting Reward-Relevant Nicotinic Receptors in the Discovery of Novel Pharmacotherapeutic Agents to Treat Tobacco Dependence
  di: Dwoskin, Linda P., et al.
  Pubblicazione: (2009)
• The novel nicotinic receptor antagonist N,N′-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbens
  di: Rahman, Shafiqur, et al.
  Pubblicazione: (2008)
• Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-picolinium)-12-triethylammonium-dodecane dibromide (TMPD)
  di: Dwoskin, Linda P., et al.
  Pubblicazione: (2007)
• bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse
  di: Wooters, Thomas E, et al.
  Pubblicazione: (2011)